The market expects Agios Pharmaceuticals (AGIO) to deliver a year-over-year decline in earnings on higher revenues when it reports results for the quarter ended March 2025. This widely-known ...

We sell different types of products and services to both investment professionals and individual investors. These products and services are usually sold through license agreements or subscriptions ...

But one sector - pharmaceuticals - is still waiting to learn what taxes it faces, with the US president expected to place tariffs on the industry in the coming days, vowing on 8 April that they ...

In a report released today, Alec Stranahan from Bank of America Securities maintained a Buy rating on Agios Pharma (AGIO – Research Report), with a price target of $52.00. The company’s shares ...

Currently, the analyst consensus on Agios Pharma is a Moderate Buy with an average price target of $56.17, representing a 106.96% upside. In a report released on April 3, RBC Capital also ...

The battleground is a controversial campaign ad. The target is the Marcos administration. The attacker is Vice President Sara Duterte. And the collateral damage is Sen. Imee Marcos, who has become a ...

It was a different case for Vice President Sara Duterte, who saw her approval and trust ratings recover in the latest polls. From 52 percent in February, approval for the Vice President increased ...

“Delaying Medicare negotiation for small-molecule drugs – the most commonly used medications – is a clear giveaway to Big Pharma. It would hand drug companies four additional years to price ...

In an April 11th letter to European Commission president Ursula von der Leyen, pharma executives said the sector was facing a “crisis”, in part due to the burgeoning trade war between the US ...